ID KCNJ9_RAT Reviewed; 393 AA. AC Q63511; DT 01-NOV-1997, integrated into UniProtKB/Swiss-Prot. DT 15-JUL-1999, sequence version 2. DT 24-JAN-2024, entry version 157. DE RecName: Full=G protein-activated inward rectifier potassium channel 3; DE Short=GIRK-3; DE AltName: Full=Inward rectifier K(+) channel Kir3.3; DE AltName: Full=Potassium channel, inwardly rectifying subfamily J member 9; GN Name=Kcnj9; Synonyms=Girk3; OS Rattus norvegicus (Rat). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Rattus. OX NCBI_TaxID=10116; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=Brain; RX PubMed=8670306; DOI=10.1006/bbrc.1996.0918; RA Dissmann E., Wischmeyer E., Spauschus A., Pfeil D.V., Karschin C., RA Karschin A.; RT "Functional expression and cellular mRNA localization of a G protein- RT activated K+ inward rectifier isolated from rat brain."; RL Biochem. Biophys. Res. Commun. 223:474-479(1996). RN [2] RP SEQUENCE REVISION. RA Dissmann E., Wischmeyer E., Spauschus A., Pfeil D.V., Karschin C., RA Karschin A.; RL Submitted (NOV-1997) to the EMBL/GenBank/DDBJ databases. RN [3] RP INTERACTION WITH SNX27, AND MUTAGENESIS OF 390-GLU--VAL-393; LYS-392 AND RP VAL-393. RX PubMed=17828261; DOI=10.1038/nn1953; RA Lunn M.L., Nassirpour R., Arrabit C., Tan J., McLeod I., Arias C.M., RA Sawchenko P.E., Yates J.R. III, Slesinger P.A.; RT "A unique sorting nexin regulates trafficking of potassium channels via a RT PDZ domain interaction."; RL Nat. Neurosci. 10:1249-1259(2007). RN [4] RP X-RAY CRYSTALLOGRAPHY (1.68 ANGSTROMS) OF 388-393 IN COMPLEX WITH SNX27, RP INTERACTION WITH SNX27, AND MUTAGENESIS OF 388-GLU-SER-389. RX PubMed=21422294; DOI=10.1073/pnas.1018645108; RA Balana B., Maslennikov I., Kwiatkowski W., Stern K.M., Bahima L., Choe S., RA Slesinger P.A.; RT "Mechanism underlying selective regulation of G protein-gated inwardly RT rectifying potassium channels by the psychostimulant-sensitive sorting RT nexin 27."; RL Proc. Natl. Acad. Sci. U.S.A. 108:5831-5836(2011). CC -!- FUNCTION: This receptor is controlled by G proteins. Inward rectifier CC potassium channels are characterized by a greater tendency to allow CC potassium to flow into the cell rather than out of it. Their voltage CC dependence is regulated by the concentration of extracellular CC potassium; as external potassium is raised, the voltage range of the CC channel opening shifts to more positive voltages. The inward CC rectification is mainly due to the blockage of outward current by CC internal magnesium (By similarity). {ECO:0000250}. CC -!- SUBUNIT: Associates with GIRK1 to form a G-protein-activated CC heteromultimer pore-forming unit (By similarity). Interacts (via PDZ- CC binding motif) with SNX27 (via PDZ domain); the interaction is required CC when endocytosed to prevent degradation in lysosomes and promote CC recycling to the plasma membrane. {ECO:0000250, CC ECO:0000269|PubMed:17828261, ECO:0000269|PubMed:21422294}. CC -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein. CC -!- DOMAIN: The PDZ-binding motif specifically binds the PDZ domain of CC SNX27: the specificity for SNX27 is provided by the 2 residues located CC upstream (Glu-388 and Ser-389) of the PDZ-binding motif CC (PubMed:17828261, PubMed:21422294). {ECO:0000269|PubMed:17828261, CC ECO:0000269|PubMed:21422294}. CC -!- SIMILARITY: Belongs to the inward rectifier-type potassium channel CC (TC 1.A.2.1) family. KCNJ9 subfamily. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; L77929; AAB95433.1; -; mRNA. DR RefSeq; NP_446286.1; NM_053834.1. DR PDB; 3QDO; X-ray; 1.88 A; A=388-393. DR PDB; 3QE1; X-ray; 1.68 A; A=388-393. DR PDB; 3QGL; X-ray; 3.31 A; F/G/H/I/J=388-393. DR PDBsum; 3QDO; -. DR PDBsum; 3QE1; -. DR PDBsum; 3QGL; -. DR AlphaFoldDB; Q63511; -. DR SMR; Q63511; -. DR STRING; 10116.ENSRNOP00000071010; -. DR iPTMnet; Q63511; -. DR PhosphoSitePlus; Q63511; -. DR PaxDb; 10116-ENSRNOP00000010113; -. DR ABCD; Q63511; 1 sequenced antibody. DR Ensembl; ENSRNOT00000010113.5; ENSRNOP00000010113.2; ENSRNOG00000007645.6. DR Ensembl; ENSRNOT00055037575; ENSRNOP00055030648; ENSRNOG00055021892. DR Ensembl; ENSRNOT00060039489; ENSRNOP00060032675; ENSRNOG00060022766. DR GeneID; 116560; -. DR KEGG; rno:116560; -. DR AGR; RGD:621440; -. DR CTD; 3765; -. DR RGD; 621440; Kcnj9. DR eggNOG; KOG3827; Eukaryota. DR GeneTree; ENSGT01080000257365; -. DR HOGENOM; CLU_022738_11_0_1; -. DR InParanoid; Q63511; -. DR OMA; RFSPMML; -. DR OrthoDB; 4126787at2759; -. DR PhylomeDB; Q63511; -. DR TreeFam; TF313676; -. DR Reactome; R-RNO-1296041; Activation of G protein gated Potassium channels. DR Reactome; R-RNO-997272; Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits. DR EvolutionaryTrace; Q63511; -. DR PRO; PR:Q63511; -. DR Proteomes; UP000002494; Chromosome 13. DR Bgee; ENSRNOG00000007645; Expressed in frontal cortex and 11 other cell types or tissues. DR ExpressionAtlas; Q63511; baseline and differential. DR GO; GO:0034702; C:monoatomic ion channel complex; IEA:UniProtKB-KW. DR GO; GO:0098688; C:parallel fiber to Purkinje cell synapse; ISO:RGD. DR GO; GO:0005886; C:plasma membrane; IBA:GO_Central. DR GO; GO:0042734; C:presynaptic membrane; ISO:RGD. DR GO; GO:0015467; F:G-protein activated inward rectifier potassium channel activity; IEA:InterPro. DR GO; GO:0005242; F:inward rectifier potassium channel activity; IBA:GO_Central. DR GO; GO:0030165; F:PDZ domain binding; IPI:UniProtKB. DR GO; GO:1990573; P:potassium ion import across plasma membrane; IBA:GO_Central. DR GO; GO:0034765; P:regulation of monoatomic ion transmembrane transport; IBA:GO_Central. DR GO; GO:0099505; P:regulation of presynaptic membrane potential; ISO:RGD. DR Gene3D; 1.10.287.70; -; 1. DR Gene3D; 2.60.40.1400; G protein-activated inward rectifier potassium channel 1; 1. DR InterPro; IPR014756; Ig_E-set. DR InterPro; IPR041647; IRK_C. DR InterPro; IPR016449; K_chnl_inward-rec_Kir. DR InterPro; IPR003276; K_chnl_inward-rec_Kir3.3. DR InterPro; IPR013518; K_chnl_inward-rec_Kir_cyto. DR InterPro; IPR040445; Kir_TM. DR PANTHER; PTHR11767:SF17; G PROTEIN-ACTIVATED INWARD RECTIFIER POTASSIUM CHANNEL 3; 1. DR PANTHER; PTHR11767; INWARD RECTIFIER POTASSIUM CHANNEL; 1. DR Pfam; PF01007; IRK; 1. DR Pfam; PF17655; IRK_C; 1. DR PIRSF; PIRSF005465; GIRK_kir; 1. DR PRINTS; PR01329; KIR33CHANNEL. DR PRINTS; PR01320; KIRCHANNEL. DR SUPFAM; SSF81296; E set domains; 1. DR SUPFAM; SSF81324; Voltage-gated potassium channels; 1. DR Genevisible; Q63511; RN. PE 1: Evidence at protein level; KW 3D-structure; Ion channel; Ion transport; Membrane; Potassium; KW Potassium transport; Reference proteome; Transmembrane; KW Transmembrane helix; Transport; Voltage-gated channel. FT CHAIN 1..393 FT /note="G protein-activated inward rectifier potassium FT channel 3" FT /id="PRO_0000154952" FT TOPO_DOM 1..57 FT /note="Cytoplasmic" FT /evidence="ECO:0000250" FT TRANSMEM 58..82 FT /note="Helical; Name=M1" FT /evidence="ECO:0000250" FT TOPO_DOM 83..106 FT /note="Extracellular" FT /evidence="ECO:0000250" FT INTRAMEM 107..118 FT /note="Helical; Pore-forming; Name=H5" FT /evidence="ECO:0000250" FT INTRAMEM 119..125 FT /note="Pore-forming" FT /evidence="ECO:0000250" FT TOPO_DOM 126..134 FT /note="Extracellular" FT /evidence="ECO:0000250" FT TRANSMEM 135..156 FT /note="Helical; Name=M2" FT /evidence="ECO:0000250" FT TOPO_DOM 157..393 FT /note="Cytoplasmic" FT /evidence="ECO:0000250" FT REGION 1..23 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 360..393 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOTIF 120..125 FT /note="Selectivity filter" FT /evidence="ECO:0000250" FT MOTIF 390..393 FT /note="PDZ-binding" FT SITE 150 FT /note="Role in the control of polyamine-mediated channel FT gating and in the blocking by intracellular magnesium" FT /evidence="ECO:0000250" FT MUTAGEN 388..389 FT /note="ES->RR,RS: Abolishes interaction with SNX27." FT /evidence="ECO:0000269|PubMed:21422294" FT MUTAGEN 390..393 FT /note="Missing: Abolishes interaction with SNX27." FT /evidence="ECO:0000269|PubMed:17828261" FT MUTAGEN 392 FT /note="K->D: Abolishes interaction with SNX27." FT /evidence="ECO:0000269|PubMed:17828261" FT MUTAGEN 392 FT /note="K->E: Does not affect interaction with SNX27." FT /evidence="ECO:0000269|PubMed:17828261" FT MUTAGEN 393 FT /note="V->I: Abolishes interaction with SNX27." FT /evidence="ECO:0000269|PubMed:17828261" FT STRAND 389..392 FT /evidence="ECO:0007829|PDB:3QGL" SQ SEQUENCE 393 AA; 43965 MW; 9CF749672A996608 CRC64; MAQENAAFSP GSEEPPRRRG RQRYVEKDGR CNVQQGNVRE TYRYLTDLFT TLVDLQWRLS LLFFVLAYAL TWLFFGAIWW LIAYGRGDLE HLEDTAWTPC VNNLNGFVAA FLFSIETETT IGYGHRVITD QCPEGIVLLL LQAILGSMVN AFMVGCMFVK ISQPNKRAAT LVFSSHAVVS LRDGRLCLMF RVGDLRSSHI VEASIRAKLI RSRQTLEGEF IPLHQTDLSV GFDTGDDRLF LVSPLVISHE IDAASPFWEA SRRALERDDF EIVVILEGMV EATGMTCQAR SSYLVDEVLW GHRFTSVLTL EDGFYEVDYA SFHETFEVPT PSCSARELAE AAARLDAHLY WSIPSRLDEK VEEEGAGEGA GAGDGADKEQ NGCLPPPESE SKV //